PHGE (STOCKS)
BiomX Inc.
$5.400000
-1.140000 (-17.43%)
Prev close: $6.540000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jonathan Eithan Solomon
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $13.97M
- Employees
- 57
- P/E (TTM)
- -0.18
- P/B (TTM)
- -0.98
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-5.51 | $-6.20 | +0.6916 | +11.15% |
|
Jun 2025 (Q2)
|
$-3.61 | $-6.30 | +2.6885 | +42.68% |
|
Mar 2025 (Q1)
|
$-7.03 | $-6.98 | -0.0532 | -0.76% |
|
Dec 2024 (Q4)
|
$-13.49 | $-21.22 | +7.7311 | +36.43% |
Financial Statements
| Research and Development | $22.77M |
| Operating Income/Loss | -$40.41M |
| Income/Loss From Continuing Operations After Tax | -$37.38M |
| Income/Loss From Continuing Operations Before Tax | -$37.37M |
| Income Tax Expense/Benefit | $9.00K |
| Net Income/Loss | -$37.38M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$37.38M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.15M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$11.90M |
| Preferred Stock Dividends And Other Adjustments | -$11.90M |
| Basic Earnings Per Share | $1.95 |
| Diluted Earnings Per Share | $1.71 |
| Basic Average Shares | 30,728,379 |
| Diluted Average Shares | 30,496,470 |
| Assets | $26.17M |
| Current Assets | $8.86M |
| Noncurrent Assets | $17.31M |
| Fixed Assets | $3.00M |
| Other Non-current Assets | $14.30M |
| Liabilities | $15.68M |
| Current Liabilities | $5.23M |
| Noncurrent Liabilities | $10.46M |
| Equity | $10.49M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $10.49M |
| Liabilities And Equity | $26.17M |
| Net Cash Flow From Operating Activities | -$28.29M |
| Net Cash Flow From Operating Activities, Continuing | -$28.29M |
| Net Cash Flow From Investing Activities | $106.00K |
| Net Cash Flow From Investing Activities, Continuing | $106.00K |
| Net Cash Flow From Financing Activities | $11.54M |
| Net Cash Flow From Financing Activities, Continuing | $11.54M |
| Exchange Gains/Losses | $65.00K |
| Net Cash Flow | -$16.58M |
| Net Cash Flow, Continuing | -$16.65M |
| Comprehensive Income/Loss | -$37.38M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$37.38M |
| Other Comprehensive Income/Loss | $0.00 |